Business● LowSep 1 · Sep 1, 2026, 8:47 AM
PMV Pharma prices $50M IPO at $1.21 per share
GlobeAlert Desk · curated from Seeking Alpha Tech · global
PMV Pharma has priced its Initial Public Offering (IPO) at $50 million, with shares offered at $1.21 each. This is a standard financial transaction for a pharmaceutical company entering the public market.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business33m agoEarn points, save cash: A basic guide to frequent-flyer programmes in EuropeEuroNews [en]Business33m agoFinancial leaders tiptoe around Beijing’s asset scrutiny, hail Hong Kong’s wealth boomSouth China Morning PostBusiness33m ago'We have proven ourselves': UAE vows to remain reliable energy supplier to EuropeEuroNews [en]Business34m agoAre Europeans saving enough for retirement? Here is how much more they need to put asideEuroNews [en]